Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Moleculin Biotech, Inc. | a2017q410-kexhibit312.htm |
| EX-32.1 - EXHIBIT 32.1 - Moleculin Biotech, Inc. | a2017q410-kexhibit321.htm |
| EX-31.1 - EXHIBIT 31.1 - Moleculin Biotech, Inc. | a2017q410-kexhibit311.htm |
| EX-32.2 - EXHIBIT 32.2 - Moleculin Biotech, Inc. | a2017q410-kexhibit322.htm |
| 10-K - 10-K - Moleculin Biotech, Inc. | a2017q410-k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 28, 2018, with respect to the financial statements included in the Annual Report of Moleculin Biotech, Inc. on Form 10-K for the year ended December 31, 2017. We consent to the incorporation by reference of said reports in the Registration Statements of Moleculin Biotech, Inc. on Form S-1 (File No. 333-214898), Form S-3 (File No. 333-219434) and Form S-8 (File No. 333-212619).
/s/GRANT THORNTON LLP
Houston, Texas
March 28, 2018